{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04429763",
      "OrgStudyIdInfo": {
        "OrgStudyId": "202001"
      },
      "Organization": {
        "OrgFullName": "Trustem",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia",
      "OfficialTitle": "Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19",
      "Acronym": "CELMA"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2020",
      "OverallStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 2020",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 2020",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "June 10, 2020",
      "StudyFirstSubmitQCDate": "June 10, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 12, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "June 10, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 12, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Trustem",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Fundación Universitaria de Ciencias de la Salud",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Hospital de San Jose",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Hospital Infantil Universitario de San Jose",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No",
      "IsUSExport": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The disease caused by the new coronavirus, SARS-CoV-2, called COVID-19, it has considered a worldwide pandemia by the WHO. Suddently, it produces a lot of patients severe ill, in a little geographic area, that could surpase the resourses of the any health system in the world.\n\nThere is no documentation of an effective alternative for the treatment of the severe ill patients, that can reduce the mortality or the adverse events suffered by these people.\n\nIt is has suggested the usefulness of the Mesenchymal Stem cells (MSC) for the management of these patients, thanks to their direct and indirect antiviral capacity, and its potency as immunomodulator, that could ameliorate the lung disease and the severity of COVID-19.",
      "DetailedDescription": "Objetive:\n\nEvaluate the effect of MSC derived from human umbilical cord compared with placebo, over the clinical progresion and mortality of hospitalized COVID-19 patients.\n\nMetodology:\n\nFase II, controled clinical trial, double blinded, compared with placebo, with paralel groups, and one to one asignation. It will be included patients between 18 and 79 years old, hositalized in general room (respiratory isolation area) with confirmed COVID-19 diagnosis. It will be excluded those who have indication for management in Intensive Care Unit, have any condition that seriusly affect their survival, pregnant whomen or breast feeding, those who have an advanced hearth failure, HIV infected, those who have a bacterial or fungal uncontroled infection, those who require permanent immunosupresive therapy or have had an organ trasplant, those who have no possibility to sign the informed consent format or are involved in another clinical trial with drugs or interventions.\n\nIt will vinculate 30 patients randomly assigned, by centralized electronic assignation sequence, for the experimental group who will received 1*10^6 cells/Kg extracted from human umbilical cord or to placebo group.\n\nThe primary result it will be a composed point of time to the occurrence of the clinical detriment or the death (the first that occurs) and the secondary result will be the components of each primary point, the clinical recovery, the time to the time to the discharge from the hospital, and the clinical follow-up, including respiratory function, and markers of inflammation, haematological and kidney, in addition of the safety markers.\n\nIt will be done a comparison of the incidence rates, by ratio of incidence rates and their respective confidence interval. It will be construct Kaplan-Meier curves that will compared by the statics of logaritmic rank (log-rank test).\n\nIt will be developed a multivariate analysis, with the Cox proportional risks methodology, estimating the Hazard Ratio epidemiologic."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "COVID-19"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal Stem Cells",
          "Umbilical Cord"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "It will be included 30 patients, randomly assigned by centralized electronic sequence of assignation, for the application of a single dosis of 1*10^6 cells/Kg or placebo",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Triple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "30",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Experimental",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Usual tratment for COVID-19 plus MSC",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Umbilical cord derived mesenchymal stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Usual treatment for COVID-19",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Placebo"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Umbilical cord derived mesenchymal stem cells",
            "InterventionDescription": "One dosis of 1*10^6 cells/Kg",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Experimental"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Placebo",
            "InterventionDescription": "Placebo",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Clinical deterioration or death",
            "PrimaryOutcomeDescription": "Change in two or more degrees in the NEWS scale",
            "PrimaryOutcomeTimeFrame": "4 weeks"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSevere COVID-19.\nInfection confirmed by PCR test.\nHospitalized in general room (respiratory isolation area).\n\nExclusion Criteria:\n\nShock or multiorgan disfunction that require continous vital signs monitorization\nPunctuation equal or more than 7 in the National Early Warning Score (NEWS) - 2 scale.\nCondition that seriously affects the patient survival expectancies, including any active cancer, hemorragia, any blood disease or severe malnutrition.\nPregnant women or breast feeding.\nAdvanced hearth failure.\nVIH/AIDS.\nBacterial or fungical uncontroled infection.\nPermanente use of immunosupresants or have had received an organ trasnplanted in the past six months.\nImposibility to sign the informent consent format.\nPatients involved in another clinical trial with drugs or interventions.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "79 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Jhon Jaime Sprockel Díaz, MD, Esp",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+573538000",
            "CentralContactEMail": "jjsprockel@fucsalud.edu.co"
          },
          {
            "CentralContactName": "Carolina Araque, MD, Esp",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+574377540",
            "CentralContactEMail": "caroaraque@gmail.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Guillermo Sánchez-Vanegas, MD, PhD",
            "OverallOfficialAffiliation": "Fundación Universitaria de Ciencias de la Salud",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Carlos Escobar-Soto, MD, PhD",
            "OverallOfficialAffiliation": "Trustem",
            "OverallOfficialRole": "Study Director"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000086382",
            "ConditionMeshTerm": "COVID-19"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012141",
            "ConditionAncestorTerm": "Respiratory Tract Infections"
          },
          {
            "ConditionAncestorId": "D000007239",
            "ConditionAncestorTerm": "Infections"
          },
          {
            "ConditionAncestorId": "D000011024",
            "ConditionAncestorTerm": "Pneumonia, Viral"
          },
          {
            "ConditionAncestorId": "D000011014",
            "ConditionAncestorTerm": "Pneumonia"
          },
          {
            "ConditionAncestorId": "D000014777",
            "ConditionAncestorTerm": "Virus Diseases"
          },
          {
            "ConditionAncestorId": "D000018352",
            "ConditionAncestorTerm": "Coronavirus Infections"
          },
          {
            "ConditionAncestorId": "D000003333",
            "ConditionAncestorTerm": "Coronaviridae Infections"
          },
          {
            "ConditionAncestorId": "D000030341",
            "ConditionAncestorTerm": "Nidovirales Infections"
          },
          {
            "ConditionAncestorId": "D000012327",
            "ConditionAncestorTerm": "RNA Virus Infections"
          },
          {
            "ConditionAncestorId": "D000008171",
            "ConditionAncestorTerm": "Lung Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M2562",
            "ConditionBrowseLeafName": "COVID-19",
            "ConditionBrowseLeafAsFound": "COVID-19",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M13056",
            "ConditionBrowseLeafName": "Pneumonia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9435",
            "ConditionBrowseLeafName": "Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5520",
            "ConditionBrowseLeafName": "Communicable Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14130",
            "ConditionBrowseLeafName": "Respiratory Tract Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13066",
            "ConditionBrowseLeafName": "Pneumonia, Viral",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16674",
            "ConditionBrowseLeafName": "Virus Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19643",
            "ConditionBrowseLeafName": "Coronavirus Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5707",
            "ConditionBrowseLeafName": "Coronaviridae Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22838",
            "ConditionBrowseLeafName": "Nidovirales Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14301",
            "ConditionBrowseLeafName": "RNA Virus Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC01",
            "ConditionBrowseBranchName": "Infections"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}